Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

The impact of gender and NASH on chronic kidney disease before and after liver transplantation
Fussner, Lynn A. , Fan, Chun , Dierkhising, Ross , Coss, Elizabeth, Watt, Kymberly D. , Charlton, Michael , Heimbach, Julie K.

Liver International | November 5, 2013 | Volume: 34 | Issue: 8 | Pages: 1259-1266

10.1111/liv.12381 | PMID 24262002 Get It

AbstractBackground & AimsChronic kidney disease (CKD) after liver transplant (LT) is associated with increased long‐term mortality. The impact of gender on CKD before and after LT is unknown. To further define risk factors and analyse gender differences in the incidence and progression of CKD after liver transplant.MethodsFour hundred and fifty‐five consecutive adult primary solitary LT recipients were included. Iothalamate clearance tests performed over time were analysed.ResultsMean age was 51.4 ± 10.4 years with 63% males. A percentage of 29.1% of females and 21.1% of males had a GFR<60 ml/min/1.73 m2 and 10.2% of females and 5.9% of males had GFR<30 ml/min/1.73 m2 prior to transplant. At 1 year, 52.6% of recipients tested (69.6% females, 43.0% males) had GFR<60 ml/min/1.73 m2 and 7.3% (11.6% females, 4.9% males) had GFR<30 ml/min/1.73 m2. Pre‐LT GFR<60 ml/min/1.73 m2 [OR 3.28, (1.76–6.10), P ≤ 0.001], female gender (OR 2.96, (1.72–5.10), P < 0.001) and age [OR 1.09, (1.05–1.12), P < 0.001] were independently predictive of stage ≥3 CKD at 1 year post‐LT. Female gender [OR 2.52, (1.25–4.71), P = 0.004], age [OR 1.05, (1.02–1.08), P = 0.003] and NASH [OR 2.95, (1.06–8.21), P = 0.039] were independently predictive of ≥stage 3 CKD at 5 years post‐LT. Pre‐LT diabetes was associated with stage 4 CKD at 5 years [OR 2.91, (1.33–6.36), P = 0.008] post‐LT.ConclusionsIn addition to age and pre‐LT CKD, female gender and NASH are independent predictors of ≥stage 3 CKD post‐LT. Gender‐based approaches to optimize modifiable risk factors are needed to improved post‐transplant renal function.
Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease
Benzinger, Tammie L.S. , Blazey, Tyler , Xiong, Chengjie , Raichle, Marcus E. , Ances, Beau M. , Bateman, Randall J. , Cairns, Nigel J., Fagan, Anne M. , Goate, Alison , Marcus, Daniel S. , Aisen, Paul, Christensen, Jon, Ercole, Lindsay, Hornbeck, Russ C. , Farrar, Angela, Aldea, Patricia, Jasielec, Mateusz S., Owen, Christopher J. , Xie, Xianyun, Mayeux, Richard , Klunk, William E. , Mathis, Chester A. , Ringman, John M. , Thompson, Paul M. , Saykin, Andrew J. , Johnson, Keith A. , Salloway, Stephen , Correia, Stephen , Schofield, Peter R. , Masters, Colin L. , Villemagne, Victor L. , Martins, Ralph N. , Ourselin, Sébastien , Rossor, Martin N. , Fox, Nick C. , Cash, David M. , Weiner, Michael W. , Buckles, Virginia, Moulder, Krista L., Morris, John C. , Jack, Clifford R. , Koeppe, Robert A. , Su, Yi , Xiong, Chengjie , Snyder, Abraham Z. , Brickman, Adam M. , McDade, Eric , Ghetti, Bernardino , Sperling, Reisa Anne , Rowe, Christopher Cleon , Holtzman, David M. , Saykin, Andrew J , Schofield, Peter R , Thompson, Paul M , Bateman, Randall J , Masters, Colin L , Benzinger, Tammie L S , Ances, Beau M , Fox, Nick C , Morris, John C , Cash, David M , Goate, Alison M

Proceedings of the National Academy of Sciences | November 5, 2013 | Volume: 110 | Issue: 47 | Pages: No page available

10.1073/pnas.1317918110 | PMID 24194552 Get It

Significance Beta-amyloid plaque accumulation, glucose hypometabolism, and neuronal atrophy are hallmarks of Alzheimer’s disease. However, the regional ordering of these biomarkers prior to dementia remains untested. In a cohort with Alzheimer’s disease mutations, we performed an integrated whole-brain analysis of three major imaging techniques: amyloid PET, [ 18 F]fluro-deoxyglucose PET, and structural MRI. We found that most gray-matter structures with amyloid plaques later have hypometabolism followed by atrophy. Critically, however, not all regions lose metabolic function, and not all regions atrophy, even when there is significant amyloid deposition. These regional disparities have important implications for clinical trials of disease-modifying therapies.
Calcium: Too Much of a Good Thing?
Millstine, Denise , Bergstrom, Larry , Mayer, Anita P.

Journal of Women's Health | November 5, 2013 | Volume: 22 | Issue: 11 | Pages: 997-999

10.1089/jwh.2013.4596 | PMID 24192309 Get It

Faculty Opinions recommendation of Assessment of female patients with rectal intussusception and prolapse: is this a progressive spectrum of disease?
Chua, Heidi K

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 5, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718163821.793486168 Get It

First quantification of alpha‐Gal epitope in current glutaraldehyde‐fixed heart valve bioprosthesis (by Naso et al.)
Byrne, Guerard W. , McGregor, Christopher G.A.

Xenotransplantation | November 5, 2013 | Volume: 21 | Issue: 1 | Pages: 11-12

10.1111/xen.12072 | PMID 24188452 Get It

Clinical Worsening in Reversible Cerebral Vasoconstriction Syndrome
Katz, Brian, Fugate, Jennifer E. , Lereis, Virginia Pujol , Mandrekar, Jay , Flemming, Kelly D. , Kallmes, David F. , Katz, Brian S, Ameriso, Sebastian Francisco , Rabinstein, Alejandro A. , Flemming, Kelly D

JAMA Neurology | November 4, 2013 | Volume: 71 | Issue: 1 | Pages: 68

10.1001/jamaneurol.2013.4639 | PMID 24190097 Get It

Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma
Han, Dale , Shyr, Yu , Chen, Heidi , Berry, Lynne D. , Iyengar, Sanjana, Djulbegovic, Mia , Weber, J, Marzban, Suroosh S., Sondak, Vernon K. , Messina, Jane L. , Vetto, John T. , White, Richard L. , Pockaj, Barbara A. , Mozzillo, Nicola, Charney, Kim, Avisar, Eli , Kashani–Sabet, Mohammed , Leong, Stanley P. L. , Zager, Jonathan S. , Krouse, Robert S.

Journal of Clinical Oncology | November 4, 2013 | Volume: 31 | Issue: 35 | Pages: 4387-4393

10.1200/jco.2013.50.1114 | PMID 24190111 Get It

Purpose Indications for sentinel lymph node biopsy (SLNB) for thin melanoma are continually evolving. We present a large multi-institutional study to determine factors predictive of sentinel lymph node (SLN) metastasis in thin melanoma. Patients and Methods Retrospective review of the Sentinel Lymph Node Working Group database from 1994 to 2012 identified 1,250 patients who had an SLNB and thin melanomas (≤ 1 mm). Clinicopathologic characteristics were correlated with SLN status and outcome. Results SLN metastases were detected in 65 (5.2%) of 1,250 patients. On univariable analysis, rates of Breslow thickness ≥ 0.75 mm, Clark level ≥ IV, ulceration, and absence of regression differed significantly between positive and negative SLN groups (all P < .05). These four variables and mitotic rate were used in multivariable analysis, which demonstrated that Breslow thickness ≥ 0.75 mm (P = .03), Clark level ≥ IV (P = .05), and ulceration (P = .01) significantly predicted SLN metastasis with 6.3%, 7.0%, and 11.6% of the patients with these respective characteristics having SLN disease. Melanomas < 0.75 mm had positive SLN rates of < 5% regardless of Clark level and ulceration status. Median follow-up was 2.6 years. Melanoma-specific survival was significantly worse for patients with positive versus negative SLNs (P = .001). Conclusion Breslow thickness ≥ 0.75 mm, Clark level ≥ IV, and ulceration significantly predict SLN disease in thin melanoma. Most SLN metastases (86.2%) occur in melanomas ≥ 0.75 mm, with 6.3% of these patients having SLN disease, whereas in melanomas < 0.75 mm, SLN metastasis rates are < 5%. By using a 5% metastasis risk threshold, SLNB is indicated for melanomas ≥ 0.75 mm, but further study is needed to define indications for SLNB in melanomas < 0.75 mm.
Shared decision-making and comparative effectiveness research for patients with chronic conditions: an urgent synergy for better health
Gionfriddo, Michael R. , Leppin, Aaron L. , Brito, Juan P. , Shah, Nilay D. , Montori, Víctor M. , LeBlanc, Annie , Montori, Victor M , Brito, Juan P

Journal of Comparative Effectiveness Research | November 4, 2013 | Volume: 2 | Issue: 6 | Pages: 595-603

10.2217/cer.13.69 | PMID 24236798 Get It

Chronic conditions are the most important cause of morbidity, mortality and health expense in the USA. Comparative effectiveness research (CER) seeks to provide evidence supporting the relative value of alternative courses of action. This research often concludes with estimates of the likelihood of desirable and undesirable outcomes associated with each option. Patients with chronic conditions should engage with their clinicians in deciding which of these options best fits their goals and context. In practicing shared decision-making (SDM), clinicians and patients should make use of CER to inform their deliberations. In these ways, SDM and CER are interrelated. SDM translates CER into patient-centered practice, while CER provides the backbone evidence about options and outcomes in SDM interventions. In this review, we explore the potential for a SDM–CER synergy in improving healthcare for patients with chronic conditions.
Medical Indications for Weight-Loss Surgery in Adolescents
Sarr, Michael G.

JAMA Pediatrics | November 4, 2013 | Volume: 168 | Issue: 1 | Pages: 11

10.1001/jamapediatrics.2013.4496 | PMID 24190664 Get It

US Military Primary Care: Problems, Solutions, And Implications For Civilian Medicine
Mundell, Benjamin F. , Friedberg, Mark W. , Eibner, Christine, Mundell, William C.

Health Affairs | November 4, 2013 | Volume: 32 | Issue: 11 | Pages: 1949-1955

10.1377/hlthaff.2013.0586 | PMID 24191085 Get It